Study Details

Back
Study ID 3662-CL-0049
Study Title A Phase 2a Randomized, Double-Blind, Multicenter, Placebo and Active Controlled Study to Assess Analgesic Efficacy and Safety of ASP3662 in Subjects with Painful Diabetic Peripheral Neuropathy
Clinicaltrials.gov Identifier NCT02372578
Compound Name ASP3662
Medical Indication or Disease Painful diabetic neuropathy
Study Sponsor Astellas Pharma Global Development, Inc.
Collaborator Not Applicable
Study Start Date 27-May-2015
Study Completion Date 20-May-2016
Clinical Study Result
Select the language
English
Plain Language Summary
Select the language
English

QUICK SEARCH

USEFUL LINKS